Prakt. lékáren. 2011; 7(2): 68-70 [Urolog. pro Praxi, 2010; 11(2): 64-67]

Prevention of recurrent urinary tract infections in practice

MUDr.Ladislava Lyerová, CSc.1, Mgr.Jana Gregorová2
1 Ambulance nefrologie, Dialyzační středisko BBraun Avitum Bulovka s. r. o., Praha
2 Oddělení klinické farmacie, Fakultní nemocnice Na Bulovce, Praha

Recurrent urinary tract infections (UTIs) are a most frequent clinical problem affecting particularly women. Long-term use of antibiotic

prophylaxis, although effective, has its limitations making search for alterative treatments an option. Our recommendation for the prevention

of recurrent UTIs is to use herbal remedies containing cranberry products, D-mannose or nasturtium. Also effective is improvement

of microflora using both oral and vaginal probiotics. However, the most important role in the prevention of these infections is

played by immunotherapy represented primarily by oral vaccines (Uro-Vaxom, Urivac). The efficacy of this product has been confirmed

by a number of studies and meta-analyses. A greater role in clinical practice could be possibly played by vaginal immunization using vaccines

against a variety of pathogens other than E. coli, particularly the vaccine against colonization by Proteus mirabilis currently under

development. In conclusion, immunotherapy can be recommended as a safe, effective and much needed alternative in the prevention

of recurrent urinary tract infections.

Keywords: recurrent urinary tract infections, cranberry products, D-mannose, nasturtium, Uro-Vaxom, Urivac, vaccination

Published: April 5, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lyerová L, Gregorová J. Prevention of recurrent urinary tract infections in practice. Praktické lékárenství. 2011;7(2):68-70.
Download citation

References

  1. Foxman B, Somsel P, Tallman P. Urinary tract infection among women aged 40-65: behavioral and sexual risc factors. J Clin Epidemiol 2001; 54(7): 710-718. Go to original source... Go to PubMed...
  2. Stamm WE, Mc Kevitt M, Robersts PL, White NJ. Natural history of recurrent urinary tract infecions in women. Rev Infect Dis 1991; 13: 77-84. Go to original source... Go to PubMed...
  3. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection on women. Can J Urol 2002; 9(3): 1558-1562.
  4. Miller JL, Krieger JN. Urinary tract infections cranberry juice, underwear, and probiotics in the 21st century. Urol Clin North Am 2002; 29(3): 695-699. Go to original source... Go to PubMed...
  5. Kleinwachter M, Schung E, Selmer D. Glucosinolate-Myrosinase System in Nasturtium (Tropaeolum majus L.): Variability of Biochemical Parameters and Screening for Clones Feasible for Pharmaceutical Utilization. J Agric Food Chem 2008; 56(23): 11165-11170. Go to original source... Go to PubMed...
  6. Albrecht U, Goos KH, Schneider B. A randomised, doubleblind, placebo-controlled trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horse radish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections, Current Medical Research and Opinion 2007; 23(10): 2415-2422. Go to original source... Go to PubMed...
  7. Huber M, Baier W, Serr A, Bessler WG. Immunogenicity of an E. coli extract after oral or intraperitoneal administration: induction of antibodies against pathogenic bacterial strains. Int J Immunopharmacol 2000; 22: 57-68. Go to original source... Go to PubMed...
  8. Lee SJ, Kim SW, Cho JH, Yoon MS. Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysacharide induced cystitis. World J Urol 2006; 24: 33-38. Go to original source... Go to PubMed...
  9. Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ. A live-attenuated vaccine for treatment of urinary tract infection by uropathogenic Escherichia coli. J Infect Dis 2009; 15, 200(2): 263-272. Go to original source... Go to PubMed...
  10. Frey C, Obolensky W, Wyss H. Treatment of recurrent urinary tract infections: efficacy of an orally administered biological response modifier. Urol Int 1986; 41: 444-446. Go to original source... Go to PubMed...
  11. Tammen H. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. The German Urinary Tract Infection Study Group. Br J Urol 1990; 65: 6-9. Go to original source... Go to PubMed...
  12. Schulman CC, Corbusier A, Michiels H, Taenzer HJ. Oral immunotherapy of recurrent urinary tract infections: a double-blind placebo-controlled multicenter study J Urol 1993; 150: 917-921. Go to original source... Go to PubMed...
  13. Magasi P, Panovics J, Illes A, Nagy M. Uro-Vaxom and the management of recurrent urinary tract infection in adults: a randomized multicenter double-blind trial. Eur Urol 1994; 26: 137-140. Go to original source... Go to PubMed...
  14. Koukalová D, Kročová Z, Vítek P, Macela A, Hájek V. Imunostimulační aktivita vakcíny pro léčbu recidivujících uroinfekcí. I. Bratislavské lékařské listy 1999; 100: 215-217. Go to PubMed...
  15. Krčméry S, Hromec J. Dlhodobá chemoprofylaxia a imunoterapia v prevencii recidivujících uroinfekcií u žien. Via pract 2006; 3(4): 190-193.
  16. Uehling DT, Hopkins WJ, Elkahwaji JE, Schmidt DM, Leverson GE. Phase 2 clinical trial of vaginal mucosal vaccine for urinary tract infections. J Urol 2003; 170(3): 867-869. Go to original source... Go to PubMed...




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.